Pinnacles

Pinnacles Medical was awarded the Best Enterprise Award for IVD and Life Sciences of the Year by Zhuoyue List

On April 3, 2022, Haoyue Capital, an industrial investment bank focusing on China's medical and health care, officially released the "2022 Sixth Medical and Health Investment Excellence List". Pinnacles Medical won the "2021 Best IVD and Life Science Company" award.

 

 

As an annual authoritative list highly recognized by the industry, the Medical and Health Investment Zhuoyue List has always adhered to the principles of fairness, impartiality, objectivity and neutrality since it was released in 2017, through the form of "authoritative judges, one vote for each company" real-name voting, according to publicly disclosed information Fill in the information with each institution, comprehensively sort out the investment activity, transaction volume, transaction amount and other indicators of each medical and health investment fund, and select the annual investment institution. At the same time, the Zhuoyue List also awards awards to medical and health companies in different fields such as biomedicine, innovative medical devices, in vitro diagnostics, medical services, and smart medical care. Benchmarking and creating new opportunities for investment cooperation.

 

Starting from clinical needs, Pinnacles Medical integrates cross-border technologies, focuses on smart testing and in vitro diagnostics, and provides a complete solution for future testing needs. The company has established R&D and intelligent manufacturing centers in Shanghai, Shenzhen, Beijing, Zhengzhou, Suzhou, Hunan and other places to realize the integration of production and research.

 

Pinnacles Medical is committed to becoming a new generation platform-based in vitro diagnostic company, integrating and innovating traditional in vitro diagnostic technology with enabling technologies such as automation, robotics, and artificial intelligence, and building a smart testing and in vitro diagnostic ecosystem. Through the establishment of the BBC (Build-Buy-Collaborate) innovative development model, we will work closely with excellent peer companies, front-line medical institutions, and industry experts. Pinnacles' open research and development model includes self-research, acquisition, and cooperation methods to efficiently integrate resources and rapidly expand its own capabilities to achieve a large-scale productization and commercialization in a short period of time.

 

The smart testing that Pinnacles mainly promotes is reflected in the automation from sampling to reporting, the unified management of laboratory information and assisted clinical decision-making. Among them, three platforms and more than ten models will be launched this year, so as to provide complete unattended laboratory solutions to laboratory departments and help build smart hospitals.

 

The collaborators of Pinnacles Medical are all companions in building an ecosystem. I look forward to working with Haoyue Capital and other industry colleagues to join hands, gather momentum and seek future, and jointly contribute wisdom and strength to the steady development of China's medical and health industry.